ICON Signs Partnership Agreement with Phase Forward Agreement extends ICON EDC capabilities
Dublin, Ireland, January 29th, 2007 – ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries today announced that it has signed a technology partnership agreement with Phase Forward (NASDAQ: PFWD), for the provision of Electronic Data Capture (EDC) solutions.
This new agreement will see ICON continue to grow and expand the range of EDC services it offers its international customer base, providing customers with a greater number of technology choices and supporting their objectives to drive additional efficiencies in the drug development process through the use of technology.
“Phase Forward are a leading provider of integrated data management solutions for clinical trials and drug safety, and the new agreement will strengthen and expand the range of EDC services ICON is able to offer its clients” commented Tom O'Leary, Global Head of Data Management at ICON. “ICON has an outstanding track record in the industry in utilising technology for the benefits of our clients. By extending our existing successful EDC partnerships to include Phase Forward we can continue to offer innovative market leading technology solutions” added Tom
Commenting on the new partnership, Bob Weiler, CEO and President of Phase Forward, remarked, “By offering Phase Forward’s award winning InForm ITM technology, ICON’s clients can now take advantage of the product’s advanced functionality and our proven track record for implementing over 1300 clinical trials worldwide. Our partnership with ICON enables both companies to leverage our respective expertise and innovation to help customers optimise and accelerate the clinical development life cycle”
ICON and Phase Forward will be jointly showcasing their technology solutions at the DIA’s Clinical Data Management workshop in Tokyo, Japan from the 29th January until the 30th January 2007.
- ends -
About ICON
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1,900 development projects and over 2,300 consultancy engagements across all major therapeutic areas. ICON currently has over 4800 employees, operating from 48 locations in 30 countries. Further information is available at www.iconclinical.com
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 230 organizations and regulatory agencies worldwide. Additional information about Phase Forward is available at www.phaseforward.com
For more information, please contact:
Simon Holmes
Group Marketing Director
ICON
Tel: +353 1 2912016
Email: holmess@iconirl.com
Caroline Power
Senior Account Manager
Band & Brown Communications
Tel; +44 (0) 207 419 7309
caroline.power@bbpr.com
Back to press releases
Dublin, Ireland, January 29th, 2007 – ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries today announced that it has signed a technology partnership agreement with Phase Forward (NASDAQ: PFWD), for the provision of Electronic Data Capture (EDC) solutions.
This new agreement will see ICON continue to grow and expand the range of EDC services it offers its international customer base, providing customers with a greater number of technology choices and supporting their objectives to drive additional efficiencies in the drug development process through the use of technology.
“Phase Forward are a leading provider of integrated data management solutions for clinical trials and drug safety, and the new agreement will strengthen and expand the range of EDC services ICON is able to offer its clients” commented Tom O'Leary, Global Head of Data Management at ICON. “ICON has an outstanding track record in the industry in utilising technology for the benefits of our clients. By extending our existing successful EDC partnerships to include Phase Forward we can continue to offer innovative market leading technology solutions” added Tom
Commenting on the new partnership, Bob Weiler, CEO and President of Phase Forward, remarked, “By offering Phase Forward’s award winning InForm ITM technology, ICON’s clients can now take advantage of the product’s advanced functionality and our proven track record for implementing over 1300 clinical trials worldwide. Our partnership with ICON enables both companies to leverage our respective expertise and innovation to help customers optimise and accelerate the clinical development life cycle”
ICON and Phase Forward will be jointly showcasing their technology solutions at the DIA’s Clinical Data Management workshop in Tokyo, Japan from the 29th January until the 30th January 2007.
- ends -
About ICON
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1,900 development projects and over 2,300 consultancy engagements across all major therapeutic areas. ICON currently has over 4800 employees, operating from 48 locations in 30 countries. Further information is available at www.iconclinical.com
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 230 organizations and regulatory agencies worldwide. Additional information about Phase Forward is available at www.phaseforward.com
For more information, please contact:
Simon Holmes
Group Marketing Director
ICON
Tel: +353 1 2912016
Email: holmess@iconirl.com
Caroline Power
Senior Account Manager
Band & Brown Communications
Tel; +44 (0) 207 419 7309
caroline.power@bbpr.com